Sickle cell protection from malaria
- PMID: 23285410
- PMCID: PMC3269803
- DOI: 10.4081/hr.2011.e24
Sickle cell protection from malaria
Abstract
A linkage between presence of Sickle Haemoglobin (HbS) and protection from malaria infection and clinical manifestations in certain areas was suspected from early observations and progressively elucidated by more recent studies. Research has confirmed the abovementioned connection, but also clarified how such protection may be abolished by coexistence of sickle cell trait (HbS trait) and alpha thalassemia, which may explain the relatively low incidence of HbS trait in the Mediterranean. The mechanisms of such protective effect are now being investigated: factors of genetic, molecular and immunological nature are prominent. As for genetic factors attention is given to the role of the red blood cell (RBC) membrane complement regulatory proteins as polymorphisms of these components seem to be associated with resistance to severe malaria; genetic ligands like the Duffy group blood antigen, necessary for erythrocytic invasion, and human protein CD36, a major receptor for P. falciparum-infected RBC's, are also under scrutiny: attention is focused also on plasmodium erythrocyte-binding antigens, which bind to RBC surface components. Genome-wide linkage and association studies are now carried out too, in order to identify genes associated with malaria resistance. Only a minor role is attributed to intravascular sickling, phagocytosis and haemolysis, while specific molecular mechanisms are the object of intensive research: among these a decisive role is played by a biochemical sequence, involving activation of haeme oxygenase (HMO-1), whose effect appears mediated by carbon monoxide (CO). A central role in protection from malaria is also played by immunological factors, which may stimulate antibody production to plasmodium antigens in the early years of life; the role of agents like pathogenic CD8 T-cells has been suggested while the effects of molecular actions on the immunity mechanism are presently investigated. It thus appears that protection from malaria can be explained by interaction of different factors: the elucidation of such mechanisms may prove valuable for the prevention and treatment strategy of a disease which still affects large parts of the world.
Keywords: CD8-Tcells.; haeme-oxygenase; haemoglobin S; immunity acquisition; protection from malaria; sickle cell trait.
Conflict of interest statement
Conflict of interest: the authors report no conflicts of interest.
Similar articles
-
Enhanced phagocytosis of ring-parasitized mutant erythrocytes: a common mechanism that may explain protection against falciparum malaria in sickle trait and beta-thalassemia trait.Blood. 2004 Nov 15;104(10):3364-71. doi: 10.1182/blood-2003-11-3820. Epub 2004 Jul 27. Blood. 2004. PMID: 15280204
-
Abnormal haemoglobins in the Sudan savanna of Nigeria. II. Immunological response to malaria in normals and subjects with sickle cell trait.Ann Trop Med Parasitol. 1979 Apr;73(2):173-83. doi: 10.1080/00034983.1979.11687244. Ann Trop Med Parasitol. 1979. PMID: 386969
-
Hemoglobinopathies: slicing the Gordian knot of Plasmodium falciparum malaria pathogenesis.PLoS Pathog. 2013;9(5):e1003327. doi: 10.1371/journal.ppat.1003327. Epub 2013 May 16. PLoS Pathog. 2013. PMID: 23696730 Free PMC article. Review.
-
Comparative haematological parameters of HbAA and HbAS genotype children infected with Plasmodium falciparum malaria in Yemen.Hematology. 2014 Apr;19(3):169-74. doi: 10.1179/1607845413Y.0000000113. Epub 2013 Nov 25. Hematology. 2014. PMID: 24074341
-
Haemoglobin C and S in natural selection against Plasmodium falciparum malaria: a plethora or a single shared adaptive mechanism?Parassitologia. 2007 Dec;49(4):209-13. Parassitologia. 2007. PMID: 18689228 Review.
Cited by
-
Utilization patterns of malaria chemoprophylaxis among Tanzanian children attending sickle cell clinic in Dar es Salaam tertiary hospitals.Malar J. 2019 Dec 3;18(1):393. doi: 10.1186/s12936-019-3029-y. Malar J. 2019. PMID: 31796035 Free PMC article.
-
Dihydroartemisinin-piperaquine or sulphadoxine-pyrimethamine for the chemoprevention of malaria in children with sickle cell anaemia in eastern and southern Africa (CHEMCHA): a protocol for a multi-centre, two-arm, double-blind, randomised, placebo-controlled superiority trial.Trials. 2023 Apr 5;24(1):257. doi: 10.1186/s13063-023-07274-4. Trials. 2023. PMID: 37016392 Free PMC article.
-
Human Genomic Loci Important in Common Infectious Diseases: Role of High-Throughput Sequencing and Genome-Wide Association Studies.Can J Infect Dis Med Microbiol. 2018 Mar 20;2018:1875217. doi: 10.1155/2018/1875217. eCollection 2018. Can J Infect Dis Med Microbiol. 2018. PMID: 29755620 Free PMC article. Review.
-
A randomized trial of artesunate-amodiaquine versus artemether-lumefantrine in Ghanaian paediatric sickle cell and non-sickle cell disease patients with acute uncomplicated malaria.Malar J. 2014 Sep 19;13:369. doi: 10.1186/1475-2875-13-369. Malar J. 2014. PMID: 25236838 Free PMC article. Clinical Trial.
-
No risk reduction for Plasmodium vivax malaria in sickle cell disease.Clin Case Rep. 2018 Apr 14;6(6):1187-1188. doi: 10.1002/ccr3.1507. eCollection 2018 Jun. Clin Case Rep. 2018. PMID: 29881595 Free PMC article.
References
-
- Valentine WN, Neil JV. Hematologic and genetic studies on the transmission of Thalassemia minor (Mediterranean anemia) Arch Int Med. 1944;74:185–196.
-
- Haldane JBS. The rate of mutation of human genes. Hereditas. 1949;35:267–73.
-
- Luzzatto L, Nwachuku-Jarrett ES, Reddy S. Increased sickling of parasitised erythrocytes as mechanism of resistance against malaria in the sickle-cell trait. Lancet. 1970;1:319–21. - PubMed
-
- Ruwende C, Hill A. Glucose-6-phosphate dehydrogenase deficiency and malaria. J Mol Med. 1998;76:581–8. - PubMed
LinkOut - more resources
Full Text Sources
Medical
Research Materials